Larimar Therapeutics LRMR
NASDAQ LRMR
$3.06 -0.13 (-4.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Non Operating Interest Expenses (2014 - 2020)

Updated

Larimar Therapeutics' Non Operating Interest Expenses was $301,000 in Q1 2020, down 39.8% from $500,000 a year earlier and down 16.9% from the prior quarter.

Analysis

Larimar Therapeutics (LRMR) Non Operating Interest Expenses (2014 - 2020) Analysis & Trends

On a trailing twelve-month basis, Larimar Therapeutics' Non Operating Interest Expenses was $1.57 million through Mar 31, 2020, down 19.2% year-over-year; for FY2019, it was $1.77 million, down 7.0% from FY2018.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of 15.2% (FY2014 to FY2019).
  • In earlier years, Non Operating Interest Expenses was $1.9 million in FY2018, $165,000 in FY2017 (-68.8%), $529,000 in FY2016 (-34.4%) and $806,000 in FY2015 (-7.4%).
  • The Q1 2020 figure marks the lowest quarterly Non Operating Interest Expenses since Q4 2017.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for three straight quarters, with growth averaging 118.9% over the last six quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2018 (growth of 779.2%); the worst was Q4 2017 (a decline of 91.8%).
  • Per Business Quant data, LRMR's Non Operating Interest Expenses in the three quarters before Q1 2020 was $362,000 (Q4 2019), $426,000 (Q3 2019) and $478,000 (Q2 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Larimar Therapeutics 331.39 Mn -275.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 301,000.00
Dec 31, 2019 362,000.00
Sep 30, 2019 426,000.00
Jun 30, 2019 478,000.00
Mar 31, 2019 500,000.00
Dec 31, 2018 499,000.00
Sep 30, 2018 475,000.00
Jun 30, 2018 466,000.00
Mar 31, 2018 458,000.00
Dec 31, 2017 8,000.00
Sep 30, 2017 31,000.00
Jun 30, 2017 53,000.00
Mar 31, 2017 73,000.00
Dec 31, 2016 97,000.00
Sep 30, 2016 132,000.00
Jun 30, 2016 140,000.00
Mar 31, 2016 160,000.00
Dec 31, 2015 180,000.00
Sep 30, 2015 200,000.00
Jun 30, 2015 213,000.00
API Access

Larimar Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LRMR&period=max&api_key=YOUR_API_KEY